FDA approves Paradym defibrillators (Sorin) for patients at risk of Cardiac Arrest

The FDA has approved the Paradym RF family of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT-D) devices, from Sorin, for patients at risk of sudden Cardiac Arrest, including some whose heart failure can be managed by cardiac resynchronization therapy. These new heart devices, including the single-chamber Paradym RF VR, the dual-chamber Paradym RF DR and the Paradym RF CRT-D, are designed to be monitored remotely. The devices have now been launched in the US.